Nuvation Bio Inc (NUVB)
3.245
-0.08
(-2.55%)
USD |
NYSE |
May 10, 16:00
3.245
0.00 (0.00%)
After-Hours: 19:39
Nuvation Bio 1 Year Total Returns (Daily): 106.8% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 09, 2024 | 106.8% |
| May 08, 2024 | 98.77% |
| May 07, 2024 | 91.02% |
| May 06, 2024 | 90.42% |
| May 03, 2024 | 101.2% |
| May 02, 2024 | 101.9% |
| May 01, 2024 | 98.76% |
| April 30, 2024 | 85.71% |
| April 29, 2024 | 83.23% |
| April 26, 2024 | 63.41% |
| April 25, 2024 | 58.79% |
| April 24, 2024 | 52.00% |
| April 23, 2024 | 47.25% |
| April 22, 2024 | 47.25% |
| April 19, 2024 | 49.43% |
| April 18, 2024 | 48.28% |
| April 17, 2024 | 48.62% |
| April 16, 2024 | 56.11% |
| April 15, 2024 | 60.00% |
| April 12, 2024 | 72.67% |
| April 11, 2024 | 81.03% |
| April 10, 2024 | 73.30% |
| April 09, 2024 | 76.50% |
| April 08, 2024 | 76.50% |
| April 05, 2024 | 85.88% |
| Date | Value |
|---|---|
| April 04, 2024 | 98.86% |
| April 03, 2024 | 108.6% |
| April 02, 2024 | 107.8% |
| April 01, 2024 | 122.3% |
| March 28, 2024 | 126.1% |
| March 27, 2024 | 146.6% |
| March 26, 2024 | 75.61% |
| March 25, 2024 | 37.20% |
| March 22, 2024 | 40.00% |
| March 21, 2024 | 28.74% |
| March 20, 2024 | 14.97% |
| March 19, 2024 | 21.95% |
| March 18, 2024 | 37.80% |
| March 15, 2024 | 39.02% |
| March 14, 2024 | 31.93% |
| March 13, 2024 | 50.62% |
| March 12, 2024 | 42.07% |
| March 11, 2024 | 45.73% |
| March 08, 2024 | 39.43% |
| March 07, 2024 | 39.11% |
| March 06, 2024 | 34.27% |
| March 05, 2024 | 16.58% |
| March 04, 2024 | 13.37% |
| March 01, 2024 | 20.54% |
| February 29, 2024 | -3.61% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.45%
Minimum
Dec 15 2022
146.6%
Maximum
Mar 27 2024
-40.26%
Average
-49.07%
Median
1 Year Total Returns (Daily) Benchmarks
| iBio Inc | -91.38% |
| Flora Growth Corp | -64.85% |
| Lixte Biotechnology Holdings Inc | -51.46% |
| Replimune Group Inc | -64.29% |
| ABVC BioPharma Inc | -88.04% |